Bausch Health Companies Inc. Stock – Fundamental Analysis
Fundamental Data & Ratios (Balance sheet update: 3/7/2026)
| Balance Sheet | Total Assets | 26,366,000,000.00 | ROE | -2.10 % |
| Balance Sheet | Total Equity | -554,000,000.00 | ROA | 0.59 % |
| Cashflow | Capital Expenditures | -407,000,000.00 | P/FCF | 2.20 |
| Cashflow | Free Cash Flow | 993,000,000.00 | – | – |
| Cashflow | Operating Cash Flow | 1,400,000,000.00 | P/CF | 1.56 |
| Income | Earnings per Share (diluted) | 0.42 | Div. Yield | – |
| Income | Net Income | 155,278,000.00 | P/E | 14.02 |
| Income | Shares Outstanding | 370,532,000.00 | P/B | -3.94 |
| Income | Total Revenue | 10,156,000,000.00 | P/S | 0.21 |
Ratios calculated on: 10/14/2026
Company Description
Valeant Pharmaceuticals International, Inc. is a pharmaceutical and medical device company. The Company is engaged in developing and marketing a range of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products, and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices). It operates through two segments: Developed markets and Emerging markets. In the Developed Markets segment, it focuses on the areas of dermatology, neurology, gastrointestinal disorders, and eye health therapeutic classes. In the Emerging Markets segment, it focuses on primarily on branded generics, OTC products and medical devices. Its pharmaceutical products include Xifaxan, Solodyn and Glumetza. Its OTC products include PreserVision, Biotrue and Boston. Its other generic products include Latanoprost and Metronidazole. Its ophthalmic surgical products include intraocular lenses, such as Akreos, enVista, Crystalens and Trulign.
Additional comparison and history views are available after login.
Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.valeant.com
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown.
Learn more